Moore JE, Lutz WBThe natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors. J Chron Dis1955; 1: 297.
2.
Alarcón-Segovia D., Osmundson PJPeripheral vascular syndromes associated with systemic lupus erythematosus. Ann Intern Med1965; 62: 907-19.
Harris EN, Gharavi AE, Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet1983; 2: 1211-14.
5.
Loizou S., McCrea JD, Rudge AC, Reynolds R., Boyle CC, Harris ENMeasurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol1985; 62: 738-45.
Alarcón-Segovia D., Delezé M., Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine1989 ; 68: 353-65.
8.
Alarcón-Segovia D., Sánchez-Guerrero J.Primary antiphospholipid syndrome. J Rheumatol1989; 16: 482-8.
9.
Mackworth-Young CG, Loizou S., Walport MJPrimary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis1989; 48: 352-7.
10.
Asherson RA , Khamashta MA, Ordi-Ros J. et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine1989; 68: 366-74.
11.
Font J., Lopez-Soto A., Cervera R. et al. The 'primary antiphospholipid syndrome': antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity1991; 9: 69-75.
12.
Khamashta MA , Cervera R., Asherson RA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet1990 ; 335: 1541-4.
13.
Cervera R., Khamashta MA, Font J. et al. High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome. Lupus1991; 1: 43-7.
14.
Asherson RA, DerksenRWHM, Harris EN, Hughes GRV Chorea in systemic lupus and lupus-like disease: association with anti-phospholipid antibodies. Semin Arthritis Rheum1987; 16: 253-9.
15.
Alarcón-Segovia D.Clinical manifestations of the antiphospholipid syndrome. J Rheumatol1992; 19: 1778-81.
16.
Alarcón-Segovia D., Pérez-Vázquez ME, Villa AR, Drenkard C., Cabiedes J.Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum1992; 21: 275-86.
17.
Pérez-Vázquez ME, Villa AR, Drenkard C., Cabiedes J., Alarcón-Segovia D.Influence of disease duration, continued follow-up and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. J Rheumatol1993; 20: 437-42.
18.
Drenkard C., Villa AR, Alarcón-Segovia D., Pérez-Vázquez MEInfluence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol1994 ; 21: 1067-72.
19.
Rivero SJ, Díaz-Jouanen E., Alarcón-Segovia D.Lymphopenia in systemic lupus erythematosus. Arthritis Rheum1978; 21: 295-305.
20.
Pérez-Vázquez ME, Cabiedes J., Cabral AR, Alarcón-Segovia D.Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors . Am J Med1992; 92: 357-62.
21.
Vianna JL, Khamashta MA, Ordi-Ros J. et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med1994; 96: 3-9.
22.
Cabral AR, Cabiedes J., Alarcón-Segovia D.Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelin-treated human erythrocytes. J Autoimmunity1990; 3: 773-87.
23.
Linder E., Edgington TSAntigenic specificity of anti-erythrocyte autoantibody responses by NZB mice: identification and partial characterization of two erythrocyte surface autoantigens . J Immunol1972; 108: 1615-23.
24.
McNeil HP, Simpson RJ, Chesterman CN, Krilis SAAntiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA1990; 87: 4120-4.
25.
Galli M., Comfurius P., Maassen C. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet1990 ; 335: 1544-7.
26.
Matsuura E. , Igarashi Y., Fujimoto M., Ichikawa K., Koike T.Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet1990 ; 336: 177-8 (letter).
